Aspira Women's Health Inc. — News

Virtual Special Meeting of Stockholders to be held August 28, 2026 NEW YORK, July 13, 2026 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH," "Ascend," or the "Company") (CSE: AAWH-U.CN) (OTCQX: AAWH), a multi-state, vertically integrated cannabis operator and consumer packaged goods company, today announced that it has filed a definitive proxy statement with the U.S. Securities and Exchange Commission ("SEC") in connection with a Special Meeting of Stockholders (the "Special Meeting") to approve a reverse stock split (the "Reverse Stock Split") of the Company's Class A common stock (the "Class A Common Shares"). "A reverse stock split is a necessary step on our path to a listing on a major U.S. exchange," said Sam Brill, CEO & Director of AWH.

prnewswire.com - 2026-07-13 08:00:00

NEW YORK, June 30, 2026 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH," "Ascend," or the "Company") (CSE: AAWH-U.CN) (OTCQX: AAWH), a multi-state, vertically integrated cannabis operator and consumer packaged goods company, today announced that it has filed applications with the U.S. Drug Enforcement Administration ("DEA") to register certain state-licensed medical cannabis operations under the expedited registration pathway established in connection with the rescheduling of medical marijuana to Schedule III of the Controlled Substances Act. "This is an important first step for medical cannabis patients and the medical community, while laying the groundwork for broader normalization across the industry," said Sam Brill, CEO & Director of AWH.

prnewswire.com - 2026-06-30 08:00:00

Collaboration aims to accelerate biomarker discovery, strengthen translational research capabilities, and support scalable clinical validation AUSTIN, TX AND CLEVELAND, OH / ACCESS Newswire / May 26, 2026 / Aspira Women's Health Inc. (OTCQX:AWHL) ("Aspira" or the "Company"), a bio-analytical company focused on the development of AI-powered, noninvasive diagnostics for women's health, and Cleveland Clinic have signed an agreement to improve women's health diagnostics. Under the terms of this Master Collaboration and License Agreement, Aspira and Cleveland Clinic will collaborate on research projects focused on the discovery and validation of novel biomarker signatures and the development of advanced analytical models intended to improve diagnostic accuracy, clinical utility, and patient care.

accessnewswire.com - 2026-05-26 09:02:00

Generated Q1 2026 net revenue of $116.9 million and Adjusted EBITDA1 of $26.3 million 51-location footprint to date, with five dispensaries added in 20262 Ranked No. 2 brand house in Illinois, Massachusetts, and New Jersey combined in Q1 20263 Rescheduling poised to unlock immediate and near-term benefits, with potential further impact from follow-on actions NEW YORK, May 13, 2026 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH," "Ascend," or the "Company") (CSE: AAWH-U.CN) (OTCQX: AAWH), a multi-state, vertically integrated cannabis operator and consumer packaged goods company, today reported its financial results for the quarter ended March 31, 2026 ("Q1 2026").

prnewswire.com - 2026-05-13 16:00:00

NEW YORK, April 29, 2026 /PRNewswire/ - Ascend Wellness Holdings, Inc. ("AWH", "Ascend" or the "Company") (CSE: AAWH-U) (OTCQX: AAWH), a leading, multi-state, vertically integrated cannabis operator and consumer packaged goods company, today announced that it will hold a conference call on Wednesday, May 13, 2026, at 5:00 p.m. ET following the release of its first quarter 2026 financial results.

prnewswire.com - 2026-04-29 08:00:00